Impact of Fc gamma receptor polymorphisms on efficacy and safety of daratumumab in relapsed/refractory multiple myeloma

被引：19

作者：

van de Donk, Niels W. C. J. ^{[1
]}

Casneuf, Tineke ^{[2
]}

Di Cara, Alessandro ^{[3
]}

Parren, Paul W. ^{[4
,5
,6
]}

Zweegman, Sonja ^{[1
]}

van Kessel, Berris ^{[1
]}

Lokhorst, Henk M. ^{[1
]}

Usmani, Saad Z. ^{[7
]}

Lonial, Sagar ^{[8
]}

Richardson, Paul G. ^{[9
]}

Chiu, Christopher ^{[10
]}

Mutis, Tuna ^{[1
]}

Nijhof, Inger S. ^{[1
]}

Sasser, A. Kate ^{[10
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Haematol, Amsterdam, Netherlands

[2] Janssen Res & Dev, Beerse, Belgium

[3] Quartz Bio, Geneva, Switzerland

[4] Genmab, Utrecht, Netherlands

[5] Univ Southern Denmark, Dept Canc & Inflammat Res, Inst Mol Med, Odense, Denmark

[6] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, Leiden, Netherlands

[7] Carolinas Healthcare Syst, Levine Canc Inst, Charlotte, NC USA

[8] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA USA

[9] Harvard Med Sch, Jerome Lipper Myeloma Ctr, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA

[10] Janssen Res & Dev, Spring House, PA USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 184卷 / 03期

关键词：

multiple myeloma; daratumumab; Fc gamma receptors; immunotherapy; polymorphisms; NATURAL-KILLER-CELLS; TARGETING CD38; MONOTHERAPY; ANTIBODIES;

D O I：

10.1111/bjh.15122

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：475 / 479

页数：5

共 50 条

[1] The efficacy and safety of daratumumab in relapsed and refractory multiple myeloma
贾亚静
China Medical Abstracts(Internal Medicine), 2020, 37 (03) : 189 - 189
[2] Efficacy and safety of daratumumab in the treatment of relapsed/refractory multiple myeloma
Chen, Pingping
Ma, Jiexian
Qian, Wensi
Wu, Min
Shen, Lin
Xie, Yanhui
MINERVA PEDIATRICS, 2024, 76 (01): : 121 - 123
[3] Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma
Plesner, Torben
Arkenau, Hendrik-Tobias
Lokhorst, Henk M.
Gimsing, Peter
Krejcik, Jakub
Lemech, Charlotte
Minnema, Monique C.
Lassen, Ulrik
Laubach, Jacob P.
Ahmadi, Tahamtan
Yeh, Howard
Guckert, Mary E.
Feng, Huaibao
Brun, Nikolai Constantin
Lisby, Steen
Basse, Linda
Palumbo, Antonio
Richardson, Paul G.
BLOOD, 2014, 124 (21)
[4] SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA
Plesner, T.
Arkenau, H. T.
Lokhorst, H. M.
Gimsing, P.
Krejcik, J.
Lemech, C.
Minnema, M. C.
Lassen, U.
Ahmadi, T.
Yeh, H.
Guckert, M.
Brun, N. C.
Lisby, S.
Basse, L.
Palumbo, A.
Richardson, P. G.
HAEMATOLOGICA, 2014, 99 : 104 - 104
[5] Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma.
Plesner, Torben
Arkenau, Hendrik-Tobias
Lokhorst, Henk M.
Gimsing, Peter
Krejcik, Jakub
Lemech, Charlotte Rose
Minnema, Monique
Lassen, Ulrik Niels
Ahmadi, Tahamtan
Yeh, Howard
Guckert, Mary
Brun, Nikolai C.
Lisby, Steen
Basse, Linda
Palumbo, Antonio
Richardson, Paul G.
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[6] Safety of rapid daratumumab infusion in relapsed and refractory multiple myeloma
Antonioli, Elisabetta
Attardi, Enrico
Staderini, Michela
Nozzoli, Chiara
Buzzichelli, Alessandra
Messeri, Maria
Bosi, Alberto
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E141 - E141
[7] SAFETY OF RAPID DARATUMUMAB INFUSION IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA
Attardi, E.
Antonioli, E.
Staderini, M.
Messeri, M.
Buzzichelli, A.
Nencini, V.
Fani, A.
Bosi, A.
HAEMATOLOGICA, 2019, 104 : 65 - 66
[8] Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma
Iida, Shinsuke
Ichinohe, Tatsuo
Shinagawa, Atsushi
Suzuki, Kenshi
Takezako, Naoki
Aoki, Masayuki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (04) : 460 - 467
[9] Preliminary Safety and Efficacy Data Of Daratumumab In Combination With Lenalidomide and Dexamethasone In Relapsed Or Refractory Multiple Myeloma
Plesner, Torben
Arkenau, Tobias
Lokhorst, Henk
Gimsing, Peter
Krejcik, Jakub
Lemech, Charlotte
Minnema, Monique C.
Lassen, Ulrik
Cakana, Andrew
Brun, Nikolai Constantin
Basse, Linda
Palumbo, Antonio
Richardson, Paul G.
BLOOD, 2013, 122 (21)
[10] Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma
Shinsuke Iida
Tatsuo Ichinohe
Atsushi Shinagawa
Kenshi Suzuki
Naoki Takezako
Masayuki Aoki
International Journal of Hematology, 2018, 107 : 460 - 467

← 1 2 3 4 5 →